NET PROFIT (x1000 EUR)
EMPLOYEES
Desitin Pharma A/S
Closing information (x1000 EUR)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
177
|
64
|
61 |
| Total assets |
1,317
|
935
|
990 |
| Current assets |
1,307
|
909
|
969 |
| Current liabilities |
157
|
73
|
124 |
| Equity capital |
1,159
|
1,725
|
1,733 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
88.0%
|
184.5%
|
175.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
832.5%
|
1245.2%
|
781.5% |
| Return on equity (ROE) |
15.3%
|
3.7%
|
3.5% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.